[QT prolongation and torsade de pointes--tachycardia in therapy with maprotiline].
Züchner
Helmut
H
D000077582:Amisulpride; D018687:Antidepressive Agents, Second-Generation / Q000009:adverse effects* / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001925:Brain Damage, Chronic / Q000139:chemically induced; D006323:Heart Arrest / Q000139:chemically induced; D006801:Humans; D008133:Long QT Syndrome / Q000139:chemically induced*; D008297:Male; D008376:Maprotiline / Q000009:adverse effects* / Q000627:therapeutic use; D008875:Middle Aged; D012559:Schizophrenia / Q000188:drug therapy; D013469:Sulpiride / Q000009:adverse effects* / Q000031:analogs & derivatives* / Q000627:therapeutic use; D013610:Tachycardia / Q000139:chemically induced*; D016171:Torsades de Pointes / Q000139:chemically induced*
D018687:Antidepressive Agents, Second-Generation; D014150:Antipsychotic Agents; D008376:Maprotiline; D013469:Sulpiride; D000077582:Amisulpride